UROKINASE相关论文
目的:探讨静脉内硝普钠联合透明质酸酶和尿激酶治疗透明质酸动脉栓塞大鼠腹壁皮肤缺血性病变的效果，比较添加硝普钠和不添加硝普钠......
1例70岁女性患者因终末期肾病、肾性贫血、导管相关性感染，给予低分子肝素钙、左卡尼汀、重组人促红素、头孢他啶。因疑似导管局部......
目的 关于尿激酶溶栓治疗急性脑梗死的治疗价值分析?方法 选择2018 年1 月至2019 年10 月到我院治疗的68 例急性脑梗死患者随机分......
Feasibility of continuous,catheter-directed for acute iliofemoral venous thrombosis in patients at r
Purpose: To examine the feasibility of catheter-directed thrombolysis(CDT)using continuous infusion of lowdose urokinase......
Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutane
...
Effect of low-molecular-weight heparin and urokinase on pulmonary arteries involved in pulmonary emb
...
目的探讨小剂量尿激酶联合奥扎格雷钠治疗进展性脑梗死患者的临床疗效和安全性。方法选择2012年12月至2014年12月100例进展性脑梗......
PAI-1 is the primary physiologic inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type plasminogen act......
THE LOCALIZATION OF ADRENOMEDULLIN IN RAT KIDNEY TISSUE AND ITS INHIBITORY EFFECT ON THE GROWTH OF C
Adrenomedullin（AM），anovelhypotensivepeptideoriginallyisolatedfromhumanpheochromocytoma（１），wassynthesizedinvarioustissues（２，３）．Thecalc......
The Changes of Vasoactive Substances Originated Endotheiium in Patients with Unstable Angina Pectori
Objectives To analyze the changes of vasoactive substances originated from endo- theiium in patients with unstable angin......
To investigate the expression and clinical significance of urokinase type plasminogen activator (uPA) in human gliomas ......
Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth f
AIM:To investigate the relationship of urokinase type plasminogenactivator receptor (uPAR) and vascular endothelial gro......
Transcriptional Regulation of Urokinase Receptor in High-(95D) and Low-metastatic (95C) Human Lung C
To study the transcriptional regulation of urokinase receptor (uPAR) in high- (95D) and low-metastatic (95C) human lung......
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cer
Activity of matrix metalloproteinase-9 increases following cerebral ischemia/reperfusion, and is associated with cerebra......
目的 研究尿激酶对急性心肌梗死(AMI)的治疗作用及其对血液流变学的影响,为临床治疗提供依据.方法 将96例急性心肌梗死患者分为尿......
目的分析常规尿激酶溶栓联合局部导丝碎栓和低分子肝素抗凝治疗血液透析患者动静脉内瘘栓塞的疗效,探讨其应用前景。方法30例血液......
目的研究尿激酶联合替罗非班在青年人ST段抬高性急性心肌梗死(STEMI)中的溶栓效果与安全性。方法76例青年STEMI患者根据数字表法随......
目的探讨红景天苷对急性脑梗死尿激酶静脉溶栓患者早期再灌注的保护作用。方法将符合静脉溶栓指标的98例急性脑梗死患者为研究对象......
目的探讨尿激酶溶栓治疗脑血栓的临床效果.方法选择56例脑血栓患者,随机分为观察组和对照组,观察组用尿激酶溶栓治疗,对照组给予常......
目的评定立体定向血肿抽吸和尿激酶溶解治疗高血压脑出血的临床疗效。方法将2008年4月~2012年6月收治于我院的70例高血压脑出血患......
目的探讨瑞替普酶与尿激酶溶栓治疗急性ST段抬高型心肌梗死(STEMI)临床疗效及安全性。方法对2010年1月1日~2013年12月31日收治的96......
目的：就如何进一步提高溶栓治疗后的疗效和溶栓后再梗塞造成病人再残疾的重要问题，我们探讨高压氧预防急性脑梗死溶栓后再梗塞及临床......
目的：探讨微创穿刺联合尿激酶治疗高血压脑出血的临床效果。方法将90例高血压脑出血患者分为观察组和对照组，每组各45例，对照组给予传......
目的对比瑞替普酶与尿激酶在急性ST段抬高型心肌梗死溶栓治疗的临床效果。方法选择2013年10月至2015年10月经长治医学院附属和济医......
目的比较尿激酶原、瑞替普酶及尿激酶溶栓治疗急性ST段抬高型心肌梗死的疗效及安全性。方法对符合条件的急性ST段抬高型心肌梗死患......
目的比较尿激酶与阿替普酶治疗急性脑梗死(ACI)的临床效果和安全性。方法选择急性脑梗死患者88例，采用数字表法随机分为两组，观察组4......
目的探讨经中心静脉导管引流联合尿激酶、地塞米松、异烟肼等药物胸腔注射对结核性胸膜炎预后的影响。方法选取结核性胸膜炎患者60......
目的 探讨心肺复苏(CPR)时给予溶栓药物尿激酶对心搏骤停(CA)兔脑微循环灌注的影响.方法 将20只新西兰大白兔按随机数字表法分为药......
AIM: To evaluate whether urokinase perfusion of non-heart-beating cadaveric donor livers reduces the incidence of intrah......
目的 探讨颅骨钻孔硬脑膜外血肿引流并注入尿激酶的疗效.方法 对40例(观察组)硬脑膜外血肿患者实施颅骨钻孔引流并经引流管注入尿......
目的 探讨复合治疗方法对自发性全脑室出血的应用价值.方法 对26例自发性全脑室出血的患者进行双侧交替低位侧脑室外引流加尿激酶......
Because of various thrombolytic agents now available associated with low thrombolytic specificity, large dose required f......
AIM To retrospectively compare the outcomes of catheter drainage,urokinase and ozone in management of empyema.METHODS Re......
BACKGROUND: Within 3 hours after ischemic stroke, thrombolysis can improve prognosis of patients; however, cerebral edem......
用许多非创伤性放射性核素的方法可以检查血管内的栓塞。如~(125)碘标记纤维蛋白元(fibrinogen),~(131)碘标记纤维蛋白溶酶(Plasm......
血栓症是一类严重威胁人类生命健康的疾病。作为血栓症三大药物疗法之一的纤溶疗法(纤维蛋白溶解疗法)早已受到人们的重视。尿激......
To assess the in-hospital clinical course and the long-term evolution of acute massive pulmonary embolism after thrombol......
Experimental study on mRNA and protein expression of urokinase type plasminogen activator in human b
Objective: To investigate the relationship between urokinase type plasminogen activator(uPA) activityand the malignant b......
AIM: To assess the adhesion- and abscess-reducing capacities of various concentrations of polysaccharides derived from f......
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cer
Activity of matrix metalloproteinase-9 increases following cerebral ischemia/reperfusion,and is associated with cerebral......
Pro-urokinase promotes angiogenesis but does not reduce neuronal apoptosis in infarcted cerebral tis
...
AIM: To evaluate the therapeutic effects of bone marrow-derived mesenchymal stem cells(BMSCs) with human urokinase-type ......
BECAUSE of lacking fibrin selectivity two chain urokinase-type plasminogen activator(tcu-PA),which has been used as the......
Ｅｆｅｃｔｓｏｆｐａｔｅｎｃｙｏｆｉｎｆａｒｃｔ┐ｒｅｌａｔｅｄｃｏｒｏｎａｒｙａｒｔｅｒｙｏｎａｃｕｔｅｏｕｔｃｏｍｅｉｎａｃｕｔｅｍｙｏｃａｒｄｉａｌｉｎｆａｒｃｔｉｏｎｐａｔｉｅｎｔｓｕｎｄｅｒｇｏｉｎｇｕｒｏｋｉｎａｓｅｔｈｅｒａｐｙＣｏｌａ...
Efectsofpatencyofinfarct┐relatedcoronaryarteryonacuteoutcomeinacutemyocardialinfarctionpatientsundergoingurokina......
Ｅｖａｌｕａｔｉｏｎｏｆｔｈｅｐａｔｅｎｃｙｒａｔｅｏｆｉｎｆａｒｃｔ┐ｒｅｌａｔｅｄａｒｔｅｒｙａｆｔｅｒｉｎｔｒａｖｅｎｏｕｓｕｒｏｋｉｎａｓｅｉｎａｃｕｔｅｍｙｏｃａｒｄｉａｌｉｎｆａｒｃｔｉｏｎｂｙ９０ｍｉｎｕｔｅｓａｎｇｉｏｇｒａｐｈｙＤａ...
Evaluationofthepatencyrateofinfarct┐relatedarteryafterintravenousurokinaseinacutemyocardialinfarctionby90minutes......
Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy v
AIM To compare the outcomes of transcatheter superior mesenteric artery(SMA) urokinase infusion and transjugular intrahe......
